Site Root
-
Home
-
About
-
Research
-
The research
-
About our research investment
-
Our projects
-
Dr Evangeline Jackson
-
Dr Michelle Tennant
-
Dr Ryan Cross
-
Dr Emmy Fleuren
-
Dr Noemi Fuentes-Bolanos
-
Ms Rachel Edwards
-
PhD Scholarship recipient, Lorna McLeman
-
PhD Scholarship recipient, Bryce Thomas
-
PhD Scholarship recipient, Chelsea Valentin
-
Interfant 21- infant acute lymphoblastic leukaemia Clinical Trial
-
Training Natural Killer cells for Immunotherapy for children, adolescent, and adults with sarcoma
-
Taming free radicals to silence the epigenome of kinase active paediatric cancers
-
Priming the blood-brain barrier to improve drug delivery and treatment outcomes in diffuse midline g
-
Integrating cancer germline genetics, precision medicine and oncology to optimise management of paed
-
Dr Aaminah Khan, (Early Career) - Getting to know: Col Reynolds Fellow
-
Dr David Mizrahi, (Early Career) - Getting to know: Col Reynolds Fellows
-
Dr Karin Plummer, (Early Career) - Getting to know: Col Reynolds Fellowships
-
Dr Kenny Ip, (Mid-Career) - Getting to know: Col Reynolds Fellowships
-
Dr Katherine Pillman, (Mid-Career) - Getting to know: Col Reynolds Fellowships
-
Dr Teresa Sadras, (Mid-Career) - Getting to know: Col Reynolds Fellowships
-
Dr Noa Lamm-Shalem, (Mid-Career) - Getting to know: Col Reynolds Fellowships
-
Dr Rachael Lawson, (Clinical) - Getting to know: Col Reynolds Fellowships
-
Dr Marion Mateos (Clinical) - Getting to know: Col Reynolds Fellowships
-
Dr Joseph Yuan-Mou Yang, (Clinical) - Getting to know: Col Reynolds Fellowships
-
Philipp Graber - Getting to know: PhD Scholar, Col Reynolds Fellowships
-
Jacqueline Hunter - Getting to know: PhD Scholar, Col Reynolds Fellowships
-
Megumi Hui Ai Lim - Getting to know: PhD Scholar, Col Reynolds Fellowships
-
Dr Hannah Walker - Getting to know: PhD Scholar, Col Reynolds Fellowships
-
Comprehensive analysis of gene changes in childhood cancer patients and their parents
-
Towards safe and effective immunotherapy for soft tissue sarcomas
-
Targeting the DC-T cell axis to treat glioblastoma
-
Targeting NAD metabolism to overcome therapeutic resistance in acute myeloid leukaemia
-
A new and effective combination therapy for children with brain cancer
-
Identification of Megakaryocyte and Platelet Bone Marrow Niches
-
Clinical translation of CAR T cell therapy for the treatment of sarcoma
-
RECOVER – Responding to late effects in survivors of childhood cancer
-
ANZSA Clinical Research Fellowship
-
Preclinical drug-testing to evaluate PARP inhibitors for infants with acute lymphoblastic leukaemia
-
GENIE
-
Pharmacogenetics real-time implementation of rare-toxicity predisposition (PRIORITY-P)
-
iBounce digital health educational program
-
From bench to bedside – Developing an osteosarcoma precision oncology workflow
-
Targeting the thioredoxin system as a novel strategy for DIPG
-
Identification of a sarcoma molecular prognostic and therapy resistance signature
-
INTER-EWING-1: Improving outcomes of newly diagnosed Ewing sarcoma
-
Pharmaco-phospho-proteo-genomics of paediatric high-grade glioma (HGG)
-
Reducing long-term side-effects of chemotherapy in cancer survivors
-
Exploiting the DNA damage response in paediatric sarcoma
-
Detecting chemotherapy resistance and sequencing residual malignant tissues in sarcoma treatment
-
Targeting altered serine metabolism in MLL-rearranged paediatric acute myeloid leukaemia (AML)
-
Enhancing radiation therapy to improve survival outcomes for children with aggressive brain cancer
-
Identifying the right sarcoma treatment at the right time
-
National Tumour Biobanking Network
-
Targeting IL-23 in bone and soft tissue sarcomas
-
Enhanced polyamine depletion for aggressive childhood cancers
-
Personalised targeted therapy for adolescent and young adult medulloblastoma patients
-
CONNECT-1903
-
Application of gene-silencing nanodrugs to inhibit medulloblastoma growth
-
Reboot-Kids
-
Pre-clinical anti CD-47 therapy
-
Targeting Polo-like kinase 1 as a novel therapeutic opportunity for diffuse intrinsic pontine glioma
-
The NORTH Trial
-
"Cage fighting" with neuroblastoma
-
Intraoperative immunotherapy to prevent relapse in soft tissue sarcoma
-
Using smarter new drugs to reduce long term debilitating side effects for aggressive childhood brain
-
International clinical trials support
-
Personalised Medicine: Zero Childhood Cancer
-
Exploiting CDK4/6 inhibition to treat medulloblastoma
-
Targeting the NAD pathway as a new therapeutic strategy for high-risk leukaemia in children
-
IntReALL-HR
-
Understanding the genetic basis of chemotherapy-induced cardiomyopathy
-
New state-wide Children’s and Adolescent/Young Adult Cancer Clinical Trials Unit
-
Pre-clinical development of novel immune therapy for paediatric cancers
-
Investigating drug resistance and genetic changes in Ph-like ALL in adolescents
-
Epigenetic targeted therapy in DIPG
-
Impact of treatment on late effects and survivorship on childhood cancer survivors
-
Developing treatments for vincristine-induced neuropathy
-
Development of a non-invasive diagnostic and prognostic assay for adolescent testicular cancer
-
MicroRNA drugs for the treatment of neuroblastoma
-
3D printers and mini-brains
-
Overcoming therapeutic resistance in high risk ALL using novel BH3 mimetic
-
Using targeted chemotherapies to reduce intensity of radiotherapy in medulloblastoma
-
New therapies for incurable paediatric brain tumours
-
Combinational therapeutics in high-risk infant acute lymphoblastic leukaemia
-
Reversing glucocorticoid resistance in paediatric acute lymphoblastic leukaemia – a novel epigenetic
-
Ready, Steady, School
-
Targeting FACT to inhibit MYCN-driven transcription in neuroblastoma
-
Exploring better and safer treatments for osteosarcoma
-
Therapeutic targeting transcriptional addiction in paediatric leukaemias
-
Synthetic retinoid therapy for diffuse intrinsic pontine glioma
-
Development of CAR T cell immunotherapies for paediatric patients
-
Development of personalised medicine approaches to treat medulloblastoma
-
Novel therapies for diffuse intrinsic pontine glioma (DIPG)
-
Improving chemotherapy regimens for medulloblastoma
-
Next gen sequencing to identify gene mutations in childhood cancer patients
-
New therapeutic targets for paediatric medulloblastoma
-
Novel targets to treat medulloblastoma
-
Personalised disease monitoring in childhood AML
-
Re-engage
-
Improving treatments for infant acute lymphoblastic leukaemia (iALL)
-
International DFMO clinical trial
-
Drug discovery project
-
Treatment of solid paediatric cancers with tropomyosin targeted therapy
-
Tumour Bank at CHW
-
Developing novel immunotherapies for childhood blood cancers
-
Stathmin regulation of microRNA expression in neuroblastoma cells
-
Bio-banking and personalised medicine software platform
-
Improving the cure rates of childhood brain cancer
-
Switching off genes
-
Clinical trial of new treatment for relapsed neuroblastoma
-
Evaluating potential side effects of anti-tropomyosins
-
Cytoskeletal regulation of adhesion dynamics in neuroblastoma metastases
-
Research news
-
Funding
-
Get involved
-
Join the fun
-
Shop
-
News & stories
-
Make a donation
-
Gift in Memory
-
Login